Elite Running Tied to Longer Life Expectancy
By Lori Solomon HealthDay Reporter
TUESDAY, May 14, 2024 -- Sub-four-minute mile runners have greater longevity than the general population, with results dating back as far as the 1950s, according to a study published online May 10 in the British Journal of Sports Medicine.
Stephen Foulkes, Ph.D., from Integrated Cardiovascular Exercise Physiology and Rehabilitation Laboratory at the University of Alberta in Edmonton, Canada, and colleagues used the Sub-4 Alphabetic Register to identify the first 200 athletes (100 percent male) to run a sub-four-minute mile and to examine associations with longevity.
The researchers found that 60 were deceased and 140 were still alive. Overall, sub-four-minute mile runners lived an average of 4.7 years beyond their predicted life expectancy. Longevity benefits were 9.2 years for completion in the 1950s, 5.5 years for completion in the 1960s, and 2.9 years for completion in the 1970s.
"To the best of our knowledge, this study represents the largest report of the longevity of runners to successfully run one mile in under four minutes. Whether such an elite feat has consequences for health and longevity is an important question," the authors write. "In studying the longevity of the first 200 four-minute mile runners we show that they have a longer lifespan than the general population and, as a corollary, our analysis shows that breaking previously conceived boundaries of running physiology does not come at the cost of a shortened lifespan."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.